Showing results (171-180 of 731) with videos related to
Sort By:
Pageof 74
Trends in Cancer|February 12, 2026
Lung cancer in never smokers: from early detection to preventionDeborah R Caswell, Crispin Hiley, Cian Murphy, et al.Cell|April 14, 2023
Impact of risk factors on early cancer evolutionClare E Weeden, William Hill, Emilia L Lim, et al.Mutagenesis|January 27, 2021
A comparative analysis of the mutagenicity of platinum-containing chemotherapeutic agents reveals direct and indirect mutagenic mechanismsBernadett Szikriszt, Ádám Póti, Eszter Németh, et al.Science Translational Medicine|March 31, 2012
Intratumor heterogeneity: seeing the wood for the treesTimothy A Yap, Marco Gerlinger, P Andrew Futreal, et al.Nature Reviews. Cancer|June 19, 2009
Genetic prognostic and predictive markers in colorectal cancerAxel Walther, Elaine Johnstone, Charles Swanton, et al.ESMO Open|March 14, 2018
Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanomaKok Haw Jonathan Lim, Lavinia Spain, Claire Barker, et al.Expert Opinion on Investigational Drugs|May 14, 2020
Metastatic melanoma: therapeutic agents in preclinical and early clinical developmentLaura Amanda Boos, Isla Leslie, James LarkinExpert Review of Anticancer Therapy|December 14, 2021
Atezolizumab, cobimetinib, and vemurafenib as first-line treatment for unresectable metastatic BRAF V600 mutated melanomaAndreas M Schmitt, Lucy Dumas, James LarkinExpert Opinion on Drug Safety|May 1, 2015
Safety of pembrolizumab for the treatment of melanomaJuan Martin-Liberal, Tiana Kordbacheh, James LarkinJournal of Hepatology|February 25, 2021
Activation and transcriptional profile of monocytes and CD8<sup>+</sup> T cells are altered in checkpoint inhibitor-related hepatitisCathrin L C Gudd, Lewis Au, Evangelos Triantafyllou, et al.Pageof 74